⏳
Showing Q3 2024 data
Meditor Group Ltd's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Meditor Group Ltd
•CIK: 1382333•Filing: Q3 2024
**Meditor Group Ltd** manages $48M across a concentrated portfolio of four positions. The fund exhibits a significant overweighting in EX9, representing $35.4M of its total assets. Further allocations include substantial stakes in ESPR ($6.3M), INDA ($3.5M), and EPI ($3.1M). This structure suggests a focused, high-conviction approach targeting specific market segments.
Total AUM
$48.1M
QoQ Performance
-10.9%
Positions
4
Top 10 Concentration
100.0%
Latest Filing
Q3 2024
Top Holdings Allocation
EX9
ESPR
INDA
EPI
EX973.4%
ESPR13.0%
INDA7.2%
EPI6.4%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
EX9
EXELIXIS INC
-22.3%
73.4% of portfolio
Sector Breakdown
Other100.0%
Changes from Q2 2024
↓1 decreased
Historical Filings
Q3 2024Q2 2024Q1 2024Q4 2023